
Govt panel says no to Serum Institute's Covovax trial on children aged 2-17 years
India Today
An expert government panel has recommended against granting permission to the Serum Institute of India (SII) to conduct clinical trial of Covid-19 vaccine Covovax on children in the age group 2-7 years.
An expert panel on Wednesday recommended against granting permission to Pune's Serum Institute of India (SII) for conducting the phase 2/3 trial of Covid-19 vaccine Covovax on children aged between two to 17 years, sources said. The SII had on Monday applied to the Drugs Controller General of India (DCGI) seeking permission to conduct a trial of Covovax on 920 children, 460 each in the 12-17 and 2-11 age groups, at 10 sites, news agency PTI reported.More Related News

Lalu Prasad Yadav's elder son, Tej Pratap, is speaking of wisdom and devotion again. He's no longer the Krishna bhakt that he was. He is now sporting saffron attire in Reels, and is propagating Shiva bhakti. His new Instagram handle is SantTejPratapYadav. After political and personal isolation, Teju bhaiya seems to have found solace in Rudraksha, Shiva bhajans and the Shiva Puran.












